Immuno-Oncology companies

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Accelerating life-extending therapies, treatments and cures for all myeloma patients.

Mass General Brigham Ventures is an early-stage venture capital firm founded in 2008 to advance new life science technologies emerging from Mass General Brigham…

We invest in cancer innovation, together.

We're biomedical researchers investing in a new generation of translational founders.

Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases.

Investing in the future of medicine.

Igniting the path to sustainable and affordable innovation.

Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.

Equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

Mirae Asset believes in changing the future through investment.

Pappas Capital invests exclusively in the life science sector.

At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families.

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives.

Investing in innovation for impact. Reduce cancer mortality and advance health equity.

Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. We iden…

Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.